A Case of Dermatomyositis with Coexistence of Positive Anti-MDA5 Antibodies and Anti-SSA/ RO52 Antibodies, Combined with Necrotic Skin Ulcers

被引:0
作者
Sun, Tian [1 ]
Hu, Zhong Hao [1 ]
He, Jin Shi [1 ]
Chen, Yu Chi [2 ]
Gao, Yong Xiang [2 ]
机构
[1] Chengdu Univ Tradit Chinese Med, Chengdu, Peoples R China
[2] Chengdu Univ Tradit Chinese Med, Affiliated Hosp, Chengdu, Sichuan, Peoples R China
来源
INTERNATIONAL MEDICAL CASE REPORTS JOURNAL | 2024年 / 17卷
关键词
dermatomyositis; MDA5; antibodies; SSA/RO52; immunosuppressants; INTERSTITIAL LUNG-DISEASE; GOTTRON PAPULES; ULCERATION;
D O I
10.2147/IMCRJ.S441691
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Dermatomyositis (DM) is an idiopathic inflammatory myopathy that is clinically challenging to diagnose and has a poor prognosis. It is characterized by symmetric proximal muscle weakness, muscle tenderness, dysphagia, characteristic skin rash (heliotrope rash, Gottron's sign), elevated muscle enzyme levels, abnormal electromyography, and muscle biopsy findings. DM with positive anti-MDA5 antibodies is mainly characterized by Gottron's sign, skin ulcers, facial erythema, mechanic's hands, and V-sign. In this case, the patient presented with the rare manifestation of severe necrotic skin ulcers in association with Gottron's sign, prompting us to report this case. Case Presentation: A 45-year-old female was admitted to the hospital with systemic joint pain, fatigue, multiple ulcers, and purulent discharge on both hands. Her myositis-specific antibody profile revealed positive anti-MDA5 and anti-SSA/RO52 antibodies. Treatment included a combination of glucocorticoids, immunosuppressants, gastric and liver protection, infection control, and wound care. After two weeks of treatment, the patient showed improvement in symptoms. However, on the 24th day of hospitalization, the wound at the right elbow joint ruptured and became infected, requiring debridement and skin grafting in the appropriate department. Conclusion: There has been limited research and reported cases of dermatomyositis with coexistence of positive anti-MDA5 and anti-SSA/RO52 antibodies combined with severe skin ulcers. Therefore, we present this rare case and emphasize the need for close follow-up on pulmonary involvement and skin ulcer progression, as well as timely implementation of new treatment strategies to actively improve the prognosis.
引用
收藏
页码:9 / 15
页数:7
相关论文
共 50 条
  • [21] Spontaneous Intramuscular Hemorrhage in Anti-MDA5 Positive Dermatomyositis: A Case Series and Literature Review
    Xu, Zhangling
    Lv, Xia
    Xu, Wenwen
    Ye, Yan
    Wang, Xiaodong
    Ye, Shuang
    Ding, Huihua
    Wu, Wanlong
    FRONTIERS IN MEDICINE, 2022, 8
  • [22] Cluster Analysis Using Anti-Aminoacyl-tRNA Synthetases and SS-A/Ro52 antibodies in Patients With Polymyositis/Dermatomyositis
    Ohashi, Keiji
    Sada, Ken-Ei
    Nakai, Yu
    Matsushima, Shun
    Asano, Yosuke
    Hayashi, Keigo
    Yamamura, Yuriko
    Hiramatsu, Sumie
    Miyawaki, Yoshia
    Morishita, Michiko
    Katsuyama, Takayuki
    Katsuyama, Eri
    Watanabe, Haruki
    Tatebe, Noriko
    Narazaki, Mariko
    Matsumoto, Yoshinori
    Watanabe, Katsue Sunahori
    Kawabata, Tomoko
    Wada, Jun
    JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2019, 25 (06) : 246 - 251
  • [23] Clinical significance of anti-Ro52 (TRIM21) antibodies non-associated with anti-SSA 60 kDa antibodies: Results of a multicentric study
    Ghillani, P.
    Andre, C.
    Toly, C.
    Rouquette, A. M.
    Bengoufa, D.
    Nicaise, P.
    Goulvestre, C.
    Gleizes, A.
    Dragon-Durey, M. A.
    Alyanakian, M. A.
    Chretien, P.
    Chollet-Martin, S.
    Musset, L.
    Weill, B.
    Johanet, C.
    AUTOIMMUNITY REVIEWS, 2011, 10 (09) : 509 - 513
  • [24] Anti-MDA5 positive dermatomyositis complicated with rapidly progressive interstitial lung disease - a case report
    De Backer, Eva
    Gremonprez, Felix
    Brusselle, Guy
    Depuydt, Pieter
    Van Dorpe, Jo
    Van Haverbeke, Carole
    Goeminne, Pieter C.
    Derom, Eric
    ACTA CLINICA BELGICA, 2018, 73 (06) : 413 - 417
  • [25] Clinical spectrum time course in non-Asian patients positive for anti-MDA5 antibodies
    Cavagna, L.
    Meloni, F.
    Meyer, A.
    Sambataro, G.
    Belliato, M.
    De Langhe, E.
    Cavazzana, I
    Pipitone, N.
    Triantafyllias, K.
    Mosca, M.
    Barsotti, S.
    Zampogna, G.
    Biglia, A.
    Emmi, G.
    de Visser, M.
    van der Kooi, A.
    Parronchi, P.
    Hirschi, S.
    da Silva, J. A. P.
    Scire, C. A.
    Furini, F.
    Giannini, M.
    Martinez Gonzalez, O.
    Damian, L.
    Piette, Y.
    Smith, V
    Mera-Varela, A.
    Bachiller-Corral, J.
    Cabezas Rodriguez, I
    Brandy-Garcia, A. M.
    Maurier, F.
    Perrin, J.
    Gonzalez-Moreno, J.
    Drott, U.
    Delbruck, C.
    Schwarting, A.
    Arrigoni, E.
    Sebastiani, G. D.
    Iuliano, A.
    Nannini, C.
    Quartuccio, L.
    Rodriguez Cambron, A. B.
    Blazquez Canamero, M. A.
    Blanco, I. Villa
    Cagnotto, G.
    Pesci, A.
    Luppi, F.
    Dei, G.
    Romero Bueno, F., I
    Franceschini, F.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2022, 40 (02) : 274 - 283
  • [26] Fast-Onset Diffuse Interstitial Lung Disease in Anti-MDA5 Antibodies-Associated Amyopathic Dermatomyositis
    Aissaoui, Houari
    Alsibai, Kinan Drak
    Khayath, Naji
    CLINICS AND PRACTICE, 2021, 11 (02) : 235 - 240
  • [27] HLA-DRB1 Alleles as Genetic Risk Factors for the Development of Anti-MDA5 Antibodies in Patients with Dermatomyositis
    Chen, Zhiyong
    Wang, Yan
    Kuwana, Masataka
    Xu, Xue
    Hu, Wei
    Feng, Xuebing
    Wang, Hong
    Kimura, Akinori
    Sun, Lingyun
    JOURNAL OF RHEUMATOLOGY, 2017, 44 (09) : 1389 - 1393
  • [28] Mortality risk in patients with anti-MDA5 dermatomyositis is related to rapidly progressive interstitial lung disease and anti-Ro52 antibody
    Huyan Wang
    Xin Chen
    Yan Du
    Lihua Wang
    Qiyuan Wang
    Huaxiang Wu
    Lei Liu
    Jing Xue
    Arthritis Research & Therapy, 25
  • [29] Mortality risk in patients with anti-MDA5 dermatomyositis is related to rapidly progressive interstitial lung disease and anti-Ro52 antibody
    Wang, Huyan
    Chen, Xin
    Du, Yan
    Wang, Lihua
    Wang, Qiyuan
    Wu, Huaxiang
    Liu, Lei
    Xue, Jing
    ARTHRITIS RESEARCH & THERAPY, 2023, 25 (01)
  • [30] Differences in the Clinical Characteristics and 1-Year Mortality Rates of Patients with Dermatomyositis with anti-Jo-1 and anti-MDA5 Antibodies
    Liu, Chao-Han
    Kor, Chew-Teng
    Hung, Ming-Hui
    Hsiao, Kai-Hung
    Cheng, Yen-Huang
    Tien, Ya-Chih
    JOURNAL OF IMMUNOLOGY RESEARCH, 2023, 2023